We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.3B
AUM Growth
+$270M
Cap. Flow
+$163M
Cap. Flow %
2.59%
Top 10 Hldgs %
21.06%
Holding
1,545
New
109
Increased
700
Reduced
529
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Financials 9.67%
3 Industrials 8.24%
4 Healthcare 8.22%
5 Consumer Discretionary 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGM icon
1351
Invesco Trust Investment Grade Municipals
VGM
$548M
$181K ﹤0.01%
17,625
BFLY icon
1352
Butterfly Network
BFLY
$1.89B
$178K ﹤0.01%
212,290
+125,110
+144% +$117K
BOE icon
1353
BlackRock Enhanced Global Dividend Trust
BOE
$673M
$176K ﹤0.01%
16,613
+330
+2% +$3.41K
INDI icon
1354
indie Semiconductor
INDI
$682M
$172K ﹤0.01%
27,920
-2,600
-9% -$16.5K
CALY
1355
Callaway Golf Company
CALY
$3.32B
$168K ﹤0.01%
11,000
USA icon
1356
Liberty All-Star Equity Fund
USA
$1.79B
$168K ﹤0.01%
24,729
-8,004
-24% -$54.4K
SCM icon
1357
Stellus Capital Investment Corp
SCM
$217M
$168K ﹤0.01%
12,202
-1,536
-11% -$21.2K
WIA
1358
Western Asset Inflation-Linked Income Fund
WIA
$185M
$165K ﹤0.01%
20,600
NRK icon
1359
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
$165K ﹤0.01%
14,869
-1,950
-12% -$21.1K
CSIQ icon
1360
Canadian Solar
CSIQ
$1.02B
$163K ﹤0.01%
+11,050
New +$187K
PSEC icon
1361
Prospect Capital
PSEC
$1.07B
$160K ﹤0.01%
28,922
BGY icon
1362
BlackRock Enhanced International Dividend Trust
BGY
$524M
$159K ﹤0.01%
28,567
+3,319
+13% +$17.9K
MD icon
1363
Pediatrix Medical
MD
$2.18B
$159K ﹤0.01%
21,100
-7,825
-27% -$64.7K
AVK
1364
Advent Convertible and Income Fund
AVK
$547M
$159K ﹤0.01%
13,656
ICLN icon
1365
iShares Global Clean Energy ETF
ICLN
$2.31B
$157K ﹤0.01%
11,790
-1,450
-11% -$20.3K
METV icon
1366
Roundhill Ball Metaverse ETF
METV
$209M
$157K ﹤0.01%
12,000
+500
+4% +$6.21K
STEM icon
1367
Stem
STEM
$48.4M
$152K ﹤0.01%
6,825
+5,060
+287% +$148K
MRCC
1368
DELISTED
Monroe Capital Corp
MRCC
$150K ﹤0.01%
19,699
-20,304
-51% -$150K
TLS icon
1369
Telos
TLS
$332M
$148K ﹤0.01%
36,899
-22,572
-38% -$85.7K
NVAX icon
1370
Novavax
NVAX
$1.2B
$147K ﹤0.01%
11,644
-475
-4% -$4.78K
ORAN
1371
DELISTED
Orange
ORAN
$137K ﹤0.01%
+13,710
New +$153K
WBA
1372
DELISTED
Walgreens Boots Alliance
WBA
$135K ﹤0.01%
11,137
-7,012
-39% -$119K
EVLV icon
1373
Evolv Technologies
EVLV
$995M
$131K ﹤0.01%
51,361
-1,000
-2% -$3.31K
MUI
1374
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$128K ﹤0.01%
10,354
-4,558
-31% -$54.6K
IOVA icon
1375
Iovance Biotherapeutics
IOVA
$1.82B
$128K ﹤0.01%
15,908
-717
-4% -$7.68K

Similar funds

Oppenheimer & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Oppenheimer & Co held 1,545 positions worth $6.3B, up 4.5% from $6.03B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q2 2024 filing shows 109 new, 700 increased, 529 reduced and 115 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF March: 599,727 shares worth $21.6M. The largest sale was FT Vest US Equity Deep Buffer ETF August, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q2 2024 buy was FT Vest US Equity Deep Buffer ETF March: 599,727 shares worth $21.6M.
  • Oppenheimer & Co added most to Amazon in Q2 2024, an estimated $9.44M increase.
  • Oppenheimer & Co's biggest Q2 2024 reduction was FT Vest US Equity Deep Buffer ETF August, cutting an estimated $20.5M.
  • Oppenheimer & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $6.69M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.3B portfolio in Q2 2024.
  • Oppenheimer & Co opened 109 new positions and closed 115 in Q2 2024.
  • Oppenheimer & Co's portfolio value rose 4.5% quarter-over-quarter to $6.3B.

Based on Oppenheimer & Co's 13F filing for Q2 2024, filed 8 Aug 2024.